In 1996, he left for the Michigan Molecular Institute to research dendrimers, where he was a senior associate scientist in Donald Tomalia's group.

In 2017, Balogh initiated Manuscript Clinic, a platform that helped scientists and students publish their research results in nanomedicine and nanotechnology and promoted both nanoscience and scientific writing.

In 2018, he founded Andover House, Inc.,[3] a not-for-profit online publishing company, and launched Precision Nanomedicine (PRNANO).

[6] Balogh discovered and pioneered dendrimer nanocomposites,[7] drug delivery platforms,[8] and co-invented new cancer treatments.

He published 228 scientific papers in chemistry, physics, nanotechnology, and nanomedicine, gave over 230 invited lectures, and was awarded 12 patents.

Some recent awards include a visiting professorship for Senior International Scientists at the Chinese Academy of Sciences, Beijing, the Korean Federation of Science and Technology Societies Brain Pool Program Award for Renowned Foreign Scientists to teach at Seoul National University, Seoul, Korea, and a Fulbright Teaching/Research Scholarship at Semmelweis University.